Zimbabwe has rejected a significant US health deal valued at 367 million US dollars (£272m) spanning five years over Washington's insistence on confidential information.
The decision came to light after a official document from December was leaked, revealing that President Emmerson Mnangagwa felt the arrangement was "skewed".
An official spokesperson later clarified that the United States was requesting genetic material for scientific study and commercial gain while refused to share the resulting advantages from future medical innovations.
"We are forced to start the difficult and regrettable process of ending our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for more negotiations to find a agreement agreeable to all parties so the country's critical HIV programme can be sustained.
Wider Context
This development follows a similar case in Kenya, where a court halted a similar deal with the US following concerns were filed about the safety of citizens' medical information.
After returning to office last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing government-to-government deals to boost transparency and accountability.
As per statements, 16 African countries have so far agreed to similar agreements, representing over $18.3bn in new funding.
Specifics of the Declined Deal
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently on HIV treatment via American-funded programmes," Tremont commented.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no corresponding guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," he stated.
"Effectively, our country would supply the raw materials for medical research with no assurance that the resulting innovations would be accessible to our people if a future disease outbreak emerge."
Sovereignty and Global Health
Mangwana further noted that the US's withdrawal from the global health body and its push of bilateral health agreements were undermining systems previously established through the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with potential pandemics.
"This system is designed to guarantee that when a country provides its data, the benefits – including medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage ongoing dialogue with our American counterparts on how future collaboration might be structured in a way that respects the sovereignty and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but suggested that negotiations need to persist considering a large portion of the nation's HIV programmes were funded by foreign aid.
"If technical issues arise, such as those relating to data governance or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," it said.
This impasse emphasises the ongoing tensions between accepting much-needed foreign assistance and safeguarding local interests in an ever more data-driven world.